Navigation Links
Isis Initiates Phase 2 Study Of ISIS-FXIRX In Patients Undergoing Knee Replacement Surgery
Date:10/29/2012

activity with no bleeding events observed. 

"ISIS-FXIRx is one of many maturing drugs in our pipeline and represents the broad applicability of our technology to develop novel drugs for many different diseases.  We believe that the safety profile observed thus far coupled with the robust activity we have seen for ISIS-FXIRx in both our Phase 1 study and preclinically, suggest that this drug could have a significant benefit for patients at risk of a thrombotic event.  Given the mechanism of Factor XI inhibition, we believe that the drug could be used broadly to prevent deep vein thrombosis or pulmonary embolism in many different therapeutic settings, including stroke, myocardial infarction and with surgeries such as knee or hip replacement, where additional safe and effective anti-thrombotic drugs are needed.  Our earlier work suggests that ISIS-FXIRx could be used in combination with existing therapies," said Sanjay Bhanot, M.D., Ph.D., vice president, clinical development and translational medicine at Isis. 

"TKA is one of the leading surgeries performed worldwide each year and is associated with a high incidence of venous thromboembolism," said Brett Monia, Ph.D., senior vice president, antisense drug discovery at Isis.  "By evaluating our drug in these patients, we will be able to directly compare the activity and safety of ISIS-FXIRx to a commonly prescribed anti-coagulant, enoxaparin.  With this proof-of-value data in hand, we believe that we will have a robust and comprehensive data package representing a significant licensing opportunity for us."

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic,
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
2. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
3. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
6. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
7. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
10. Empire Asset Management Co. Initiates Coverage on Transcept Pharmaceuticals Inc., (NASDAQ: TSPT)
11. Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Breckenridge Pharmaceutical, Inc. announced today that ... Laboratories Pvt. Ltd. ( Hyderabad, India ) ... new ANDAs.  Under the terms of the agreement, MSN ... Breckenridge for the U.S. market, and Breckenridge will market ... MSN have agreed to develop an oral antibiotic with ...
(Date:12/19/2014)... , Dec. 19, 2014 In today,s ... product,s web presence to reflect the needs of ... particular, must meet the needs of key stakeholders ... According to recent research by ... of the participating companies averaged more than $100,000 ...
(Date:12/19/2014)... WESTMINSTER, Colo. , Dec. 19, 2014  Monarch ... (f/k/a Cannabis Kinetics Corp.) is pleased to provide this ... for continued growth in 2015. "Over this ... corporate goals and I am extremely proud to say ... diversified position today than it has ever been," stated ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Building a Best-in-Class Pharma Global Brand Website 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3
... in September -, BRISBANE, Calif., Sept. 4 ... that the amended Clinical Trial,Authorization (CTA) related to ... been approved by the appropriate European regulatory,authorities. InterMune ... the institutions that will conduct the Phase 1b ...
... Carlo brings predictability to whole range ... of Phase II, III and IV ... Solutions, a,global leader in off-the-shelf and custom supply chain ... announced,the release of its tcVisualize(TM) 3.0 clinical trial supply ...
Cached Medicine Technology:InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191 2InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191 3Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2
(Date:12/20/2014)... Recently, VogueQueen.com, a leading wedding dress ... Sale Online for 2015. Great discounts are now ... old consumers can get a discount, up to 80% ... website before January 30, 2015. , VogueQueen.com has recently ... a prom dress promotion. Many customers worldwide like VogueQueen’s ...
(Date:12/20/2014)... December 20, 2014 The Doctor’s Office Urgent ... the better part of a decade. They’ve treated over ... better, faster healthcare alternative to the Paramus area. ... three new additions to their staff of top-notch board certified ... Zeiger MD. These new doctors will work tirelessly ...
(Date:12/20/2014)... 20, 2014 Angeldress.co.uk, the distinguished wedding ... for worldwide dress fans. The company has recently updated ... information. For the holiday season, Angeldress Blog ... wedding apparel. , Angeldress.co.uk prides itself in offering a ... of service. All the company’s outfits are very carefully ...
(Date:12/20/2014)... 20, 2014 As Risperdal lawsuits ... in U.S. courts, Bernstein Liebhard LLP notes the ... children treated with the medication may experience elevated ... development and lactation. The study, which appears in ... adolescents who began treatment with risperidone, an antipsychotic ...
(Date:12/20/2014)... 2014 Atore, Inc, (San Francisco, CA ... first birthday focused portal on December 17th, 2014. ... in both US and Japan. , MERRY BIRTHDAY SITE ... http://merrybirthday.net/message/ , MERRY BIRTHDAY MESSAGE is part of ... world. , Features, Choose from thousands of stock photos ...
Breaking Medicine News(10 mins):Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Atore, Inc. Releasing the First Birthday Portal 2
... In an effort to extend the length of a ... Baptist Medical Center are partnering with colleagues from across the ... by the US National Institute on Aging (NIA). ... aims to assess whether aspirin can not only prolong life, ...
... HealthDay Reporter , WEDNESDAY, July 7 (HealthDay News) ... cancer is less accurate when done in the summer than ... Although the particular brand of test used in the ... the United States, the findings are of interest to U.S. ...
... ... FDA reports of the shocking conditions in manufacturing plants have pediatricians and parents concerned ... ... the year there have been numerous recalls of infants’ and children’s over-the-counter (OTC) pharmaceutical ...
... detection today is X-ray mammography, which takes images of ... are several disadvantages to using X-rays for breast cancer ... and the high costs, which limit their wide use ... depending on the age of the patient and tissue ...
... D.C. (July 1, 2010) -- Thousands of scientists and ... meet at the 52nd meeting of the American Association ... 22, 2010 in Philadelphia, Pennsylvania. They will present the ... and discuss the safety and regulatory issues facing the ...
... , WEDNESDAY, July 7 (HealthDay News) -- ... chronic low back pain influence how they manage their ... ability to find, understand and use health information. Low ... in many chronic conditions, but this relationship has not ...
Cached Medicine News:Health News:Can aspirin prolong a healthy life? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 3Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 4Health News:Safety in Children's Pain Relief Products a Primary Concern 2Health News:Safety in Children's Pain Relief Products a Primary Concern 3Health News:Mathematical models for breast cancer detection with microwave tomography are cheaper and less risky 2Health News:Understanding Back Pain May Improve Management, Study Suggests 2
... Quinton Q-Stress Cardiac Stress Monitor ... wander and muscle artifact filters, ... to provide the highest ECG ... can be displayed in 3, ...
... designed to monitor, store and measure data during ... system can organize the amount of information detected ... quick review and printout of an extremely flexible ... via a small portable ECG recorder (ECT 12 ...
... Advanced Biosensor's compact BioStress 2000 is a ... and Stress testing system. The BioStress 2000 ... real-time ECG viewing, permanent ECG strorage and ... virtually any printer. BioStress 2000 allows a ...
Part of the Octopus System which includes both the Starfish & Octopus3. The Octopus3 Tissue Stabilizer is the pioneering and market-leading suction device....
Medicine Products: